Jeffrey L. Sturchio, Ph.D.
Vice President, External Affairs
Human Health Europe, Middle East & Africa
Merck & Co., Inc./WS2A-55
One Merck Drive
Whitehouse Station, NJ 08889-0100 USA
Telephone: +1 908 423 3981
GSM: +32 475 66 67 79
Fax: +1 908 735 1704

Dr. Jeffrey L. Sturchio is Vice President, External Affairs, Human Health--Europe, Middle East & Africa at Merck & Co., Inc., in Whitehouse Station, New Jersey. He is responsible for the development, coordination, and implementation of a range of health policy and communications initiatives for the region. He has been centrally involved in Merck’s participation in the UN/industry Accelerating Access Initiative to help improve HIV/AIDS care and treatment in the developing world, and he is a member of the private sector delegation on the Board of the Global Fund to Fight AIDS, TB and Malaria.

Dr. Sturchio received an A.B. in history (1973) from Princeton University and a Ph.D. in the history & sociology of science from the University of Pennsylvania (1981). His previous positions include the AT&T Archives, the Beckman Center for the History of Chemistry at the University of Pennsylvania, Rutgers University, and the New Jersey Institute of Technology. He has also been a Postdoctoral Fellow and Senior Fellow at the Smithsonian Institution's National Museum of American History (NMAH). He joined Merck in June 1989 as the Company’s first Corporate Archivist.

His publications include Chemistry in America, 1876-1976: Historical Indicators (Reidel, 1985; paperback edition, 1988), written with A. Thackray, P. T. Carroll, and R. F. Bud; Values & Visions: A Merck Century (Merck & Co., Inc., 1991); “Pharmaceutical firms and the transition to biotechnology: a study in strategic innovation” (with L. Galambos), Business History Review 72 (Summer 1998): 250-278; “Against: Direct to consumer advertising is medicalising normal human experience” (with S. Bonaccorso), British Medical Journal 324 (13 April 2002): 910-911; and “Successful public-private partnerships in global health: lessons from the MECTIZAN Donation Program,” (with B. Colatrella), in The Economics of Essential Medicines, ed. by B. Granville (London: Royal Institute of International Affairs, 2002).